Monocarboxylate Transporter 1 Deficiency, also known as ketoacidosis due to monocarboxylate transporter-1 deficiency, is related to hyperinsulinemic hypoglycemia, familial, 7 and body mass index quantitative trait locus 11. An important gene associated with Monocarboxylate Transporter 1 Deficiency is SLC16A1 (Solute Carrier Family 16 Member 1), and among its related pathways/superpathways are Metabolism and Glucose / Energy Metabolism. The drugs Zinc cation and Dapagliflozin have been mentioned in the context of this disorder. Affiliated tissues include heart and kidney, and related phenotypes are ketoacidosis and ketonuria